CASI Pharmaceuticals, Inc. – ‘10QSB’ for 6/30/96 – EX-6

As of:  Wednesday, 8/14/96   ·   For:  6/30/96   ·   Accession #:  948027-96-113   ·   File #:  0-20713

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report — Small Business   —   Form 10-QSB
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10QSB       Entremed 10QSB                                        12     56K 
 2: EX-1        Entremed Cover Ltr                                     1      8K 
 3: EX-2        Agmt Bt Cytokine & Innovative                         50    115K 
 4: EX-3        Ex 2.02(G) Consulting Agreement                        7     28K 
 5: EX-4        Ex 2.02(H) Employment Agreement                       11     29K 
 6: EX-5        Ex 10.24 Research Agreement                            9     24K 
 7: EX-6        Ex 11                                                  1      8K 
 8: EX-27       Financial Data Schedule (Pre-XBRL)                     1      8K 

EX-6   —   Ex 11

                                  Exhibit 11

ENTREMED, INC.                                                                  

COMPUTATION OF EARNINGS PER SHARE (1)                                           

                                                        [Enlarge/Download Table]

                                                            Three Months Ended            Six Months Ended      
                                                                   June 30,                      June 30,       
                                                          1996                1995      1996                1995
                                                          ------------------------      ------------------------
                                                                                                                
Weighted average common and common                                                                              
equivalent shares outstanding during the period         7,696,696       5,388,321      7,068,703      5,268,838 

Effect of common stock issued and stock options                                                                 
and warrants granted subsequent to April 12, 1995                                                               
computed in accordance with the treasury stock                                                                  
method as required by the SEC (2)                            -          1,462,163        425,663      1,731,662 
                                                   -------------------------------------------------------------

Total common and common equivalent shares               7,696,696       6,850,484      7,494,366      7,000,500 
                                                   -------------------------------------------------------------

Net loss                                            $    (464,938)   $ (1,503,921)  $ (2,140,345)  $(3,550,381) 
                                                   -------------------------------------------------------------

Net loss per share                                  $       (0.06)   $      (0.22)  $      (0.29)  $      (0.51)
                                                   -------------------------------------------------------------

(1) All share information have been adjusted to reflect a two-for-three reverse 
stock split.                                                                    

(2) Pursuant to Securities and Exchange Commission Staff Accounting Bulletin No.
83, Common and Preferred Stock issued and stock options and warrants grants at  
prices below the initial public offering price of $15.00 per share during the   
12-month period immediately preceding the initial filing date of the Company's  
Registration Statement for its initial public offering have been included as    
outstanding for all periods presented using the treasury stock method.          

Dates Referenced Herein

This ‘10QSB’ Filing		Date		Other Filings
Filed on:		8/14/96		None on these Dates
For Period End:		6/30/96
		4/12/95
				List all Filings